华仁药业：红塔创新已减持1.00%股份

Core Viewpoint - The announcement from Huaren Pharmaceutical indicates that shareholder Hongta Innovation has reduced its stake in the company by selling 11.82 million shares at an average price of 3.38 yuan, resulting in a reduction of ownership to 4.72% [1] Summary by Relevant Sections - Shareholder Activity - Hongta Innovation sold a total of 11.82 million shares through centralized bidding from August 26, 2025, to January 10, 2025 [1] - The average selling price was 3.38 yuan per share, leading to a total reduction in ownership by 1.00% [1] - After the sale, Hongta Innovation holds 55.8231 million shares, which is now below the 5% threshold for significant shareholders [1]